COLLABORATION AND LICENSE AGREEMENT (Human Vaccine)Collaboration and License Agreement • September 9th, 2024 • Alopexx, Inc. • Biological products, (no disgnostic substances) • London
THIS COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) dated as of September 05, 2024 (the “Effective Date”) is entered into by and between Alopexx, Inc., a Delaware corporation, having a principal place of business at 186 Alewife Brook Parkway #1068, Cambridge, Massachusetts 02138 USA (together with its Affiliates, subsidiaries, successors and permitted assigns, “Alopexx”), and Biotech Consortia, Inc., a Bahamas international business company, having a registered office address at Trident Trust Company (Bahamas) Ltd, 1st Floor, Building A, Caves Corporate Center, Blake Road and West Bay Street, PO Box N-3944, Nassau, Bahamas (together with its Affiliates, subsidiaries, successors and permitted assigns, “BCI”). BCI and Alopexx may be referred to each individually as a “Party” or together collectively as the “Parties.”
